Synopsis
Synopsis
0
VMF
0
South Africa
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Hydroxychlorochin
2. Hydroxychloroquine
3. Hydroxychloroquine Sulfate (1:1) Salt
4. Oxychlorochin
5. Oxychloroquine
6. Plaquenil
1. 747-36-4
2. Hydroxychloroquine Sulphate
3. Ercoquin
4. Plaquenil
5. 2-((4-((7-chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol Sulfate
6. Quensyl
7. Oxiklorin
8. Tcmdc-123987
9. Hcq Sulfate
10. Plaquenil Sulfate
11. Nsc 4375
12. Hydroxychloroquine (sulfate)
13. Oxichlorochine Sulfate
14. Nsc-4375
15. 8q2869cnvh
16. 2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric Acid
17. 2-({4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino)ethan-1-ol; Sulfuric Acid
18. Plaquinol
19. Toremonil
20. 2-((4-((7-chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethan-1-ol Sulfate
21. Dsstox_cid_27788
22. Dsstox_rid_82563
23. N4-(7-chloro-4-quinolyl)-n1-ethyl-n1-(2-hydroxyethyl)-1,4-pentanediamine Sulfate
24. Dsstox_gsid_47811
25. 2-((4-(7-chloroquinolin-4-ylamino)pentyl)(ethyl)amino)ethanol Sulfate
26. 2-((4-((7-chloroquinolin-4-yl)amino)-pentyl)(ethyl)amino)ethanol Sulfate
27. Cas-747-36-4
28. Hydroxychloroquine Sulfate [usp]
29. Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethylamino)-, Sulfate (1:1)
30. Sr-05000001881
31. Ncgc00159483-02
32. Einecs 212-019-3
33. Unii-8q2869cnvh
34. Quinoric
35. Ai3-52706
36. Plaquenil (tn)
37. Ethanol, Monosulfate
38. Mfcd00078203
39. Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-, Sulfate (1:1)
40. Hydroxychlorquine Sulfate
41. 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethylamino)ethanol Sulfate (1:1) (salt)
42. 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol Sulfate (1:1) (salt)
43. Chembl1690
44. Ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)-, Sulfate (1:1) (salt)
45. Schembl41114
46. Spectrum1503978
47. 747-36-4 (sulfate)
48. Dtxsid1047811
49. Hydroxychloroquine Sulfate ,(s)
50. Hydroxychloroquine Sulfate- Bio-x
51. Ethanol, Sulfate (1:1) (salt)
52. Hms1922o12
53. Hms2093o05
54. Hms3713j22
55. Pharmakon1600-01503978
56. Bcp12823
57. Hy-b1370
58. Tox21_111707
59. Bdbm50247975
60. Ccg-39154
61. Nsc758663
62. S4430
63. Hydroxychloroquine Sulfate (jan/usp)
64. Akos015897337
65. Tox21_111707_1
66. Cs-8017
67. Hydroxychloroquine Sulfate [mi]
68. Ks-5311
69. Nsc-758663
70. Sb19140
71. (+-)-2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol Sulfate (1:1) (salt)
72. 7-chloro-4-[4-[n-ethyl-n-(2-hydroxyethyl)amino]-1-methylbutylamino]quinoline Sulfate
73. Hydroxychloroquine Sulfate [jan]
74. Ncgc00095090-01
75. Ncgc00095090-02
76. Ncgc00159483-04
77. Bh164525
78. Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethyl)amino-, (+-)-, Sulfate (1:1) Salt
79. Hydroxychloroquine Sulfate [mart.]
80. Hydroxychloroquine Sulfate [vandf]
81. Hydroxychloroquine Sulfate [usp-rs]
82. Hydroxychloroquine Sulfate [who-dd]
83. Db-055904
84. Ft-0603511
85. Ft-0669460
86. H1306
87. Hydroxycloroquine Sulfate, Analytical Standard
88. D02114
89. H10433
90. Hydroxychloroquine Sulfate [orange Book]
91. Hydroxychloroquine Sulfate [ep Monograph]
92. 747h364
93. A838213
94. Hydroxychloroquine Sulfate [usp Monograph]
95. Hydroxychloroquine Sulfate, >=98% (hplc), Powder
96. Sr-05000001881-1
97. Sr-05000001881-2
98. W-104413
99. Q27270879
100. Z1551900864
101. Hydroxychloroquine Sulphate 1.0 Mg/ml In Methanol (as Free Base)
102. 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol Sulfate
103. Hydroxychloroquine Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material
104. Hydroxychloroquine Sulfate, United States Pharmacopeia (usp) Reference Standard
105. (+/-)-2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol Sulfate (1:1) (salt)
106. (+/-)-2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol Sulphate (1:1) (salt)
107. 14480-75-2
108. Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethyl)amino-, (+/-)-, Sulfate (1:1) Salt
109. Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethyl)amino-, (+/-)-, Sulphate (1:1) Salt
| Molecular Weight | 434.0 g/mol |
|---|---|
| Molecular Formula | C18H28ClN3O5S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 9 |
| Exact Mass | 433.1438199 g/mol |
| Monoisotopic Mass | 433.1438199 g/mol |
| Topological Polar Surface Area | 131 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 413 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Hydroxychloroquine sulfate |
| Drug Label | Hydroxychloroquine sulfate, USP is a colorless crystalline solid, soluble in water to at least 20 percent; chemically the drug is 2-[[4-[(7-Chloro-4-quinolyl) amino]pentyl] ethylamino] ethanol sulfate (1:1). Hydroxychloroquine sulfate, USP has the fo... |
| Active Ingredient | Hydroxychloroquine sulfate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 200mg |
| Market Status | Prescription |
| Company | Sandoz; Hikma Pharms; Teva Pharms; Ipca Labs; Zydus Pharms Usa; Mylan |
| 2 of 2 | |
|---|---|
| Drug Name | Hydroxychloroquine sulfate |
| Drug Label | Hydroxychloroquine sulfate, USP is a colorless crystalline solid, soluble in water to at least 20 percent; chemically the drug is 2-[[4-[(7-Chloro-4-quinolyl) amino]pentyl] ethylamino] ethanol sulfate (1:1). Hydroxychloroquine sulfate, USP has the fo... |
| Active Ingredient | Hydroxychloroquine sulfate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 200mg |
| Market Status | Prescription |
| Company | Sandoz; Hikma Pharms; Teva Pharms; Ipca Labs; Zydus Pharms Usa; Mylan |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Antirheumatic Agents
Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - 200MG
USFDA APPLICATION NUMBER - 214581
DOSAGE - TABLET;ORAL - 300MG
USFDA APPLICATION NUMBER - 214581
DOSAGE - TABLET;ORAL - 200MG
USFDA APPLICATION NUMBER - 9768
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Controlled & Modified Release
Disintegrants & Superdisintegrants
Direct Compression
Thickeners and Stabilizers
Granulation
Solubilizers
Lubricants & Glidants
Topical
Film Formers & Plasticizers
Taste Masking
Parenteral
Co-Processed Excipients
Emulsifying Agents
Rheology Modifiers
Chewable & Orodispersible Aids
API Stability Enhancers
Empty Capsules
Coloring Agents
Vegetarian Capsules
Surfactant & Foaming Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
45
PharmaCompass offers a list of Hydroxychloroquine Sulphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydroxychloroquine Sulphate manufacturer or Hydroxychloroquine Sulphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydroxychloroquine Sulphate manufacturer or Hydroxychloroquine Sulphate supplier.
PharmaCompass also assists you with knowing the Hydroxychloroquine Sulphate API Price utilized in the formulation of products. Hydroxychloroquine Sulphate API Price is not always fixed or binding as the Hydroxychloroquine Sulphate Price is obtained through a variety of data sources. The Hydroxychloroquine Sulphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Plaquinol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Plaquinol, including repackagers and relabelers. The FDA regulates Plaquinol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Plaquinol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Plaquinol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Plaquinol supplier is an individual or a company that provides Plaquinol active pharmaceutical ingredient (API) or Plaquinol finished formulations upon request. The Plaquinol suppliers may include Plaquinol API manufacturers, exporters, distributors and traders.
click here to find a list of Plaquinol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Plaquinol DMF (Drug Master File) is a document detailing the whole manufacturing process of Plaquinol active pharmaceutical ingredient (API) in detail. Different forms of Plaquinol DMFs exist exist since differing nations have different regulations, such as Plaquinol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Plaquinol DMF submitted to regulatory agencies in the US is known as a USDMF. Plaquinol USDMF includes data on Plaquinol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Plaquinol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Plaquinol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Plaquinol Drug Master File in Japan (Plaquinol JDMF) empowers Plaquinol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Plaquinol JDMF during the approval evaluation for pharmaceutical products. At the time of Plaquinol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Plaquinol suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Plaquinol Drug Master File in Korea (Plaquinol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Plaquinol. The MFDS reviews the Plaquinol KDMF as part of the drug registration process and uses the information provided in the Plaquinol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Plaquinol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Plaquinol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Plaquinol suppliers with KDMF on PharmaCompass.
A Plaquinol CEP of the European Pharmacopoeia monograph is often referred to as a Plaquinol Certificate of Suitability (COS). The purpose of a Plaquinol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Plaquinol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Plaquinol to their clients by showing that a Plaquinol CEP has been issued for it. The manufacturer submits a Plaquinol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Plaquinol CEP holder for the record. Additionally, the data presented in the Plaquinol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Plaquinol DMF.
A Plaquinol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Plaquinol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Plaquinol suppliers with CEP (COS) on PharmaCompass.
A Plaquinol written confirmation (Plaquinol WC) is an official document issued by a regulatory agency to a Plaquinol manufacturer, verifying that the manufacturing facility of a Plaquinol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Plaquinol APIs or Plaquinol finished pharmaceutical products to another nation, regulatory agencies frequently require a Plaquinol WC (written confirmation) as part of the regulatory process.
click here to find a list of Plaquinol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Plaquinol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Plaquinol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Plaquinol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Plaquinol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Plaquinol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Plaquinol suppliers with NDC on PharmaCompass.
Plaquinol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Plaquinol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Plaquinol GMP manufacturer or Plaquinol GMP API supplier for your needs.
A Plaquinol CoA (Certificate of Analysis) is a formal document that attests to Plaquinol's compliance with Plaquinol specifications and serves as a tool for batch-level quality control.
Plaquinol CoA mostly includes findings from lab analyses of a specific batch. For each Plaquinol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Plaquinol may be tested according to a variety of international standards, such as European Pharmacopoeia (Plaquinol EP), Plaquinol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Plaquinol USP).
